Dichloropane Stats & Data
O-401
Rti-111
NPS DataHub
MW328.24
FormulaC16H19Cl2NO2
IUPACmethyl 3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate
SMILES
COC(=O)C1C2CCC(CC1c1ccc(Cl)c(Cl)c1)N2CInChIKey
AMIHUYQKNJHXPT-UHFFFAOYSA-N
Psychoactive Class
Stimulant
Receptor Profile
Receptor Actions
Inhibitors
Serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI)
Other
blocks dopamine transporter (DAT IC50: 0.79 nM)
blocks serotonin transporter (SERT IC50: 3.13 nM)
blocks norepinephrine transporter (NET IC50: 18 nM)
Effect Profile
Curated
Stimulant
5.2
Strong anxiety/jitters with moderate focus and stimulation, mild euphoria
Stimulation / Energy×3
6
Euphoria / Mood Lift×2
5
Focus / Productivity×2
7
Anxiety / Jitters×1
10
Based on reports from:
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Full tolerance
1d
Half tolerance
10d
Baseline
~18d
Legal Status
| Country | Status | Notes |
|---|---|---|
| Germany | Dichloropane is not a controlled substance under the BtMG ( Narcotics Act ) or the NpSG ( New Psychoactive Substances Act ). | Technically it would fall under the definition of a medicine by §2 AMG ( Medicines Act ) because it induces a pharmacological effect. By a decision of the European Court of Justice, this definition was declared ineffective because it was not compatible with EU law. Dichloropane can be considered unregulated. |
| Switzerland | Dichloropane is a controlled substance specifically named under Verzeichnis E. | |
| United States | Dichloropane may be considered to be an analogue of cocaine under the Federal Analogue Act. | The Federal Analogue Act, 21 U.S.C. § 813, is a section of the United States Controlled Substances Act, allowing any chemical "substantially similar" to an illegal drug (in Schedule I or II) to be treated as if it were also in Schedule I or II, but only if it is intended for human consumption. |
References
Cited References
- Bluelight: RTI-111 (Dichloropane) Dosage Info Discussion
- Bluelight: RTI-111 (Dichloropane) Experience Reports
- Carroll et al. 2005: Synthesis and Monoamine Transporter Binding Properties
- Ranaldi et al. 2000: Reinforcing and Discriminative Stimulus Effects in Rhesus Monkeys
- TripSit: Drug Combinations Wiki
- TripSit: RTI-111 Factsheet